These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8252506)

  • 1. The use of flutamide in hormone-refractory metastatic prostate cancer.
    McLeod DG; Benson RC; Eisenberger MA; Crawford ED; Blumenstein BA; Spicer D; Spaulding JT
    Cancer; 1993 Dec; 72(12 Suppl):3870-3. PubMed ID: 8252506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversies in the treatment of metastatic prostate cancer.
    McLeod DG; Crawford ED; Blumenstein BA; Eisenberger MA; Dorr FA
    Cancer; 1992 Jul; 70(1 Suppl):324-8. PubMed ID: 1600494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer. Casodex Combination Study Group.
    Schellhammer P; Sharifi R; Block N; Soloway M; Venner P; Patterson AL; Sarosdy M; Vogelzang N; Jones J; Kolvenbag G
    Urology; 1995 May; 45(5):745-52. PubMed ID: 7538237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of goserelin and leuprolide in combined androgen blockade therapy.
    Sarosdy MF; Schellhammer PF; Sharifi R; Block NL; Soloway MS; Venner PM; Patterson AL; Vogelzang NJ; Chodak GW; Klein EA; Schellenger JJ; Kolvenbag GJ
    Urology; 1998 Jul; 52(1):82-8. PubMed ID: 9671875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination treatment versus LHRH alone in advanced prostatic cancer.
    Ferrari P; Castagnetti G; Ferrari G; Baisi B; Dotti A
    Urol Int; 1996; 56 Suppl 1():13-7. PubMed ID: 8776812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma.
    Crawford ED; Eisenberger MA; McLeod DG; Spaulding JT; Benson R; Dorr FA; Blumenstein BA; Davis MA; Goodman PJ
    N Engl J Med; 1989 Aug; 321(7):419-24. PubMed ID: 2503724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National Cancer Institute study of luteinizing hormone-releasing hormone plus flutamide versus luteinizing hormone-releasing hormone plus placebo.
    Benson RC; Crawford ED; Eisenberger MA; McLeod DG; Spaulding JT; Dorr FA
    Semin Oncol; 1991 Oct; 18(5 Suppl 6):9-12. PubMed ID: 1948121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leuprolide with and without flutamide in advanced prostate cancer.
    Crawford ED; Blumenstein BA; Goodman PJ; Davis MA; Eisenberger MA; McLeod DG; Spaulding JT; Benson R; Dorr FA
    Cancer; 1990 Sep; 66(5 Suppl):1039-44. PubMed ID: 2118417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate carcinoma. Analysis of time to progression. CASODEX Combination Study Group.
    Schellhammer PF; Sharifi R; Block NL; Soloway MS; Venner PM; Patterson AL; Sarosdy MF; Vogelzang NJ; Chen Y; Kolvenbag GJ
    Cancer; 1996 Nov; 78(10):2164-9. PubMed ID: 8918410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downstaging of localized prostate cancer by neoadjuvant therapy with flutamide and lupron: the first controlled and randomized trial.
    Labrie F; Dupont A; Cusan L; Gomez J; Diamond P; Koutsilieris M; Suburu R; Fradet Y; Lemay M; Têtu B
    Clin Invest Med; 1993 Dec; 16(6):499-509. PubMed ID: 8013155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total androgen blockade: the United States experience.
    Benson RC
    Eur Urol; 1993; 24 Suppl 2():72-6. PubMed ID: 8262130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral orchiectomy with or without flutamide for metastatic prostate cancer.
    Eisenberger MA; Blumenstein BA; Crawford ED; Miller G; McLeod DG; Loehrer PJ; Wilding G; Sears K; Culkin DJ; Thompson IM; Bueschen AJ; Lowe BA
    N Engl J Med; 1998 Oct; 339(15):1036-42. PubMed ID: 9761805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent androgen suppression for locally advanced and metastatic prostate cancer: preliminary report of a prospective multicenter study.
    Sato N; Akakura K; Isaka S; Nakatsu H; Tanaka M; Ito H; Masai M;
    Urology; 2004 Aug; 64(2):341-5. PubMed ID: 15302491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of newly diagnosed state D2 prostate cancer with leuprolide and flutamide or leuprolide alone, phase III, intergroup study 0036.
    Crawford ED; Allen JA
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):961-3. PubMed ID: 2126738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flutamide approved for prostate cancer.
    Oncology (Williston Park); 1989 Mar; 3(3):135. PubMed ID: 2518157
    [No Abstract]   [Full Text] [Related]  

  • 16. Flutamide withdrawal plus hydrocortisone resulted in clinical complete response in a patient with prostate carcinoma.
    Figg WD; Kroog G; Duray P; Walther MM; Patronas N; Sartor O; Reed E
    Cancer; 1997 May; 79(10):1964-8. PubMed ID: 9149024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of adrenalectomy, flutamide, and leuprolide on the growth of the Dunning rat R-3327 prostatic carcinoma.
    Kung TT; Mingo GG; Siegel MI; Watnick AS
    Prostate; 1988; 12(4):357-63. PubMed ID: 3134647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination studies with leuprolide.
    Crawford ED
    Eur Urol; 1990; 18 Suppl 3():30-3. PubMed ID: 2128828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flutamide for prostate cancer.
    Med Lett Drugs Ther; 1989 Jul; 31(797):72. PubMed ID: 2501635
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined androgen blockade: leuprolide and flutamide versus leuprolide and placebo.
    Crawford ED; Goodman P; Blumenstein B
    Semin Urol; 1990 Aug; 8(3):154-8. PubMed ID: 2119048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.